Semaglutide: GLP-1 Receptor Agonist Tackling Frailty

Semaglutide: GLP-1 Receptor Agonist Tackling Frailty and Diastolic Dysfunction in Heart Failure

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a groundbreaking treatment for various metabolic and cardiovascular conditions. Initially…

Read More »